October 2016 Newsletter

///October 2016 Newsletter

New faster rapid-acting insulin coming soon

By | 2016-12-08T23:26:34+00:00 October 18th, 2016|October 2016 Newsletter|

As fast as rapid-acting insulin is, the phrase "slower than molasses in January" is a better descriptor for how quickly it works as compared to the insulin made by a normally functioning pancreas. It takes about 4 hours for it to finish working, for crying out loud! In the not-so-distant future, we may have insulins available that improve upon the action of our currently-approved mealtime insulins.

Free support & mentoring for living with diabetes

By | 2016-12-08T23:26:34+00:00 October 18th, 2016|October 2016 Newsletter|

Tens of millions worldwide have some form of diabetes, and an estimated 60% or more don’t know anyone else in their lives who lives with diabetes as well. Are you one of them? Learn about a free support system!

Higher A1c levels seen in adult smokers with Type 1 diabetes

By | 2016-12-08T23:26:35+00:00 October 18th, 2016|October 2016 Newsletter|

Calling all smokers…did you know that if you have Type 1 and smoke, your A1c is likely higher than it would be if you were a non-smoker? That's true for your cholesterol levels, too. You can change that!

Have you been denied Medicare coverage for CGM?

By | 2016-12-08T23:26:35+00:00 October 18th, 2016|October 2016 Newsletter|

If you are a low-income Medicare beneficiary with diabetes who requires multiple daily injections of insulin, or insulin pump therapy, and also have hypoglycemia unawareness, we have some good news for you! You may be eligible to receive help with your appeal if you have been denied coverage by Medicare for a continuous glucose monitoring (CGM) system.

Bigfoot recruits for first artificial pancreas clinical trial

By | 2016-12-08T23:26:35+00:00 October 18th, 2016|October 2016 Newsletter|

Bigfoot Biomedical is making progress towards getting its artificial pancreas on the market.  The company announced in August that it obtained approval from the FDA to enroll up to 50 participants in a trial of its system in development.